// App-Quantinova.ai

P414 : Vedolizumab in Pediatric inflammatory bowel diseases: a retrospective multi-center experience from the paediatric IBD Porto group of ESPGHAN

Researchers

Presenter

  • O. Ledder

Principal Investigators

  • J. Martn de Carpi

  • L. Richmond

  • S. Cohen

  • J. Bronsky

  • R. Shaoul

  • A. Levine

  • J. Escher

  • L. deRidder

  • A. Assa

  • F. Ruemmele

  • N. Shah

  • V. Wolters

  • A. Rodrigues

  • H. Uhlig

  • D. Urlep

  • C. Posovsky

  • K. Kolho

  • D. Turner

Medical Centers

  • Shaare Zedek Medical Centre, Pediatric Gastroenterology and Nutrition, Jerusalem, Israel

  • Academic Medical Center, Amsterdam, Netherlands

  • Hospital Sant Joan de Deu de Barcelona, Barcelona, Spain

  • Royal Hospital for Sick Children, Glasgow, United Kingdom

  • Ichilov Medical Center, Tel Aviv, Israel

  • University Hospital Motol, Prague, Czech Republic

  • Rambam Medical Center, Haifa, Israel

  • Edith Wolfson Medical Center, Holon, Israel

  • Erasmus University Medical Center, Rotterdam, Netherlands

  • Schneider Childrens Medical Center, Petah Tikva, Israel

  • Hopital Necker-Enfants Malades, Paris, France

  • Great Ormond Street Hospital, London, United Kingdom

  • University Medical Center Utrecht, Utrecht, Netherlands

  • Oxford University Hospitals NHS Trust, Oxford, United Kingdom

  • Ljubljana University Medical Centre, Ljubljana, Slovenia

  • University of Heidelberg Medical Center, Heidelberg, Germany

  • Helsinki University Central Hospital Cancer Center, Helsinki, Finland

Locations

  • Israel

  • Netherlands

  • Spain

  • United Kingdom

  • Czech Republic

  • France

  • Slovenia

  • Germany

  • Finland

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

  • Infectious Diseases (ID)

  • Genetic Disorder

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Entyvio

Outcome

  • N/A


Study Design

  • Multicenteric

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A